Kisqali (400 MG Dose) and Meropenem and vaborbactam Intravenous
Determining the interaction of Kisqali (400 MG Dose) and Meropenem and vaborbactam Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Kisqali
Generic Name: meropenem / vaborbactam
Brand name: Vabomere
Synonyms: Meropenem and vaborbactam, Meropenem and Vaborbactam
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kisqali (400 MG Dose)-Meropenem Intravenous
- Kisqali (400 MG Dose)-Merrem
- Kisqali (400 MG Dose)-Merrem IV
- Kisqali (400 MG Dose)-Merthiolate
- Kisqali (400 MG Dose)-Meruvax II
- Kisqali (400 MG Dose)-Mesalamine
- Meropenem and vaborbactam Intravenous-Kisqali (600 MG Dose)
- Meropenem and vaborbactam Intravenous-Kisqali Femara Co-Pack
- Meropenem and vaborbactam Intravenous-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Meropenem and vaborbactam Intravenous-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Meropenem and vaborbactam Intravenous-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Meropenem and vaborbactam Intravenous-Kitabis Pak